X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (466) 466
Publication (156) 156
Book Chapter (11) 11
Book Review (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (239) 239
index medicus (189) 189
male (161) 161
female (143) 143
adult (115) 115
middle aged (114) 114
hematology (101) 101
aged (84) 84
article (84) 84
pathology (69) 69
immunohistochemistry (58) 58
adolescent (53) 53
hemic and lymphatic diseases (51) 51
abridged index medicus (49) 49
child (45) 45
oncology (43) 43
young adult (43) 43
expression (41) 41
animals (39) 39
aged, 80 and over (37) 37
lymphomas (37) 37
disease (36) 36
immunophenotyping (36) 36
mutation (36) 36
surgery (33) 33
cancer (30) 30
polymerase chain reaction (30) 30
b-cell lymphoma (29) 29
lymphoma (29) 29
immunology (27) 27
prognosis (27) 27
child, preschool (25) 25
mice (25) 25
activation (24) 24
rituximab (23) 23
epstein-barr virus (22) 22
non-hodgkins-lymphoma (21) 21
research (21) 21
epstein-barr-virus (20) 20
in situ hybridization (20) 20
mutations (20) 20
chemotherapy (19) 19
genetic aspects (19) 19
immune system diseases (19) 19
lymph nodes - pathology (19) 19
flow cytometry (18) 18
infectious diseases (18) 18
treatment outcome (18) 18
biopsy (17) 17
follicular lymphoma (17) 17
gene expression (17) 17
immunodeficiency (17) 17
in situ hybridization, fluorescence (17) 17
lymphocytes (17) 17
lymphoma, large b-cell, diffuse - pathology (17) 17
tumors (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
gene expression profiling (16) 16
lymphoid neoplasia (16) 16
phenotype (16) 16
t-lymphocytes - immunology (16) 16
t-lymphocytes - pathology (16) 16
apoptosis (15) 15
cell line, tumor (15) 15
clinical trials and observations (15) 15
gene rearrangement (15) 15
hodgkin disease - pathology (15) 15
lymphoma, large b-cell, diffuse - drug therapy (15) 15
therapy (15) 15
transplantation (15) 15
b-lymphocytes - pathology (14) 14
cell biology (14) 14
chronic lymphocytic-leukemia (14) 14
leukemia (14) 14
gene-expression (13) 13
lymphoproliferative disorders (13) 13
patients (13) 13
cell proliferation (12) 12
diagnosis, differential (12) 12
disease progression (12) 12
features (12) 12
follow-up studies (12) 12
gene (12) 12
genes (12) 12
herpesvirus 4, human - isolation & purification (12) 12
lymphoma, b-cell - pathology (12) 12
lymphoma, large b-cell, diffuse - genetics (12) 12
medical research (12) 12
neurosciences (12) 12
pathogenesis (12) 12
primary effusion lymphoma (12) 12
reed-sternberg cells (12) 12
survival (12) 12
t-cells (12) 12
blotting, southern (11) 11
care and treatment (11) 11
diagnosis (11) 11
doxorubicin - administration & dosage (11) 11
epstein-barr virus infections - pathology (11) 11
herpesvirus 4, human - genetics (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 169 - 176
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 15, pp. 1408 - 1416
A dose-intense infusional chemotherapy program plus rituximab had a high degree of efficacy in patients with primary mediastinal B-cell lymphoma, which is... 
MEDICINE, GENERAL & INTERNAL | AMPLIFICATION | MANAGEMENT | EFFICACY | DOXORUBICIN | SCLEROSIS | CLASSICAL HODGKIN LYMPHOMA | RADIOTHERAPY | EXPRESSION | GERMINAL-CENTER | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Filgrastim | Dose-Response Relationship, Drug | Young Adult | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Kaplan-Meier Estimate | Rituximab | Stroke Volume - drug effects | Etoposide - administration & dosage | Recombinant Proteins - administration & dosage | Disease-Free Survival | Vincristine - adverse effects | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Drugs | Dose-response relationship (Biochemistry) | Usage | Cyclophosphamide | Patient outcomes | Dosage and administration | Lymphomas | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Doxorubicin | Medical research | Nuclear magnetic resonance--NMR | Disease | Review boards | Genes | Etoposide | Prednisone | Radiation therapy | Kinases | Vincristine | Patients | Morbidity | Chemotherapy | Lymphocytes B | Remission | Mutation | Hodgkin's disease | B-cell lymphoma
Journal Article
Nature Medicine, ISSN 1078-8956, 08/2015, Volume 21, Issue 8, pp. 922 - 926
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 20, pp. 1915 - 1925
Toxic high-dose chemotherapy may not be necessary to cure Burkitt's lymphoma in adults and patients with immunodeficiency. An infusion-based chemotherapy... 
CHEMOTHERAPY REGIMEN | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | CODOX-M/IVAC | EVENT-FREE SURVIVAL | RITUXIMAB | DOXORUBICIN | NON-HODGKINS-LYMPHOMA | DOSE-ADJUSTED EPOCH | ANTIRETROVIRAL THERAPY | CHILDREN | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | HIV Seropositivity - complications | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Burkitt Lymphoma - complications | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - administration & dosage | Adolescent | Vincristine - adverse effects | Aged | Immunocompromised Host | Doxorubicin - adverse effects | Pediatrics | Laboratories | Leukemia | Nervous system | Cancer therapies | Doxorubicin | Human immunodeficiency virus--HIV | Children | Drug dosages | Neurological disorders | Neutropenia | Risk groups | Cyclin-dependent kinases | Neutrophils | Fluid | Etoposide | Rituximab | Prednisone | Vincristine | Patients | Fever | Burkitt's lymphoma | Studies | Cyclophosphamide | Chemotherapy | Lymphocytes B | Lysis | Lymphomas | B-cell lymphoma
Journal Article
Journal Article
Nature, ISSN 0028-0836, 10/2012, Volume 490, Issue 7418, pp. 116 - 120
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 15, pp. 1396 - 1407
Journal Article
Histopathology, ISSN 0309-0167, 08/2019, Volume 75, Issue 2, pp. 282 - 286
Intravascular large B cell lymphoma (IVLBCL) is a rare, aggressive, extranodal large B cell lymphoma characterised by growth of tumour cells within the lumen... 
immunohistochemistry | intravascular large B cell lymphoma | programmed cell death ligand 1 | lymphoma | MANAGEMENT | RITUXIMAB | PATHOLOGY | CHEMOTHERAPY | CELL BIOLOGY | T cells | Cell death | Lymphomas | Immunomodulation | Lymphocytes T | CD3 antigen | Cell surface | CD5 antigen | Lymphocytes B | Immunotherapy | CD20 antigen | Capillaries | Apoptosis | Tumors | B-cell lymphoma
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2010, Volume 107, Issue 19, pp. 8766 - 8771
Hepatitis B virus (HBV)-associated acute liver failure (ALF) is a dramatic clinical syndrome due to a sudden loss of hepatic cells leading to multiorgan... 
T lymphocytes | Hepatocytes | B lymphocytes | Hepatitis antigens | Liver | Kupffer cells | Plasma cells | Antibodies | Hepatitis B virus | Hepatitis B | Fulminant hepatitis B | Phage display fab library | B cell immunity | Gene expression profiling | Pathogenesis | ACTIVATION | PROTEIN | phage display Fab library | FULMINANT VIRAL-HEPATITIS | MEMBRANE | MULTIDISCIPLINARY SCIENCES | NEGATIVE REGULATOR | FAMILY | pathogenesis | fulminant hepatitis B | REJECTION | DISEASE | INFECTION | gene expression profiling | T-CELLS | Immunohistochemistry | Liver - virology | Liver - pathology | Humans | Hepatitis B - virology | Liver Failure, Acute - virology | Complement System Proteins - immunology | Gene Expression Profiling | Hepatitis B - blood | Necrosis - pathology | Necrosis - virology | T-Lymphocytes - virology | Necrosis - immunology | Young Adult | Hepatitis B - immunology | Liver - immunology | Immunoglobulin G - biosynthesis | Liver Failure, Acute - genetics | B-Lymphocytes - virology | Hepatitis B virus - immunology | Disease Progression | Hepatitis B Core Antigens - immunology | Cell Lineage | B-Lymphocytes - immunology | Liver Failure, Acute - immunology | T-Lymphocytes - immunology | Hepatitis B Antibodies - biosynthesis | Cluster Analysis | Immunoglobulin M - biosynthesis | Liver Failure, Acute - blood | Antigens | Care and treatment | Liver failure | Immunoglobulin G | Physiological aspects | Development and progression | Genetic aspects | B cells | Properties | Gene expression | Biological Sciences
Journal Article